Johnson &amp; Johnson Says Very Comfortable Moving Forward With Phase 1/2a Studies Of Experimental Coronavirus Vaccine Later This Month; Co. Executive Says Expects To Begin Early-Stage Study Of Coronavirus Vaccine In Belgium Around July 22 $JNJ